Contrarily, the loss of significance in the inverse risk association between adiponectin and endometrial cancer when considering only type 2 endometrial cancers could be attributed to the general perception that type 2 endometrial cancer is obesity independent. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.